Table 1 Baseline characteristics of the participants

Age (Year)

53.4 ± 12.1

52 ± 11.9

55.2 ± 12.1

0.04

BMI (kg/m²)

25.2 ± 3.8

25.5 ± 3.7

25.9 ± 3.9

0.22

SBP (mmHg)

125.1 ± 15.5

126.7 ± 16.1

123.1 ± 14.4

0.07

DBP (mmHg)

76.3 ± 9.7

77.3 ± 9.6

75 ± 9.7

0.07

HTN (%)

134 (57.3%)

72 (55%)

62 (60%)

0.25

DM duration (years)

6.4 ± 6.2

6.1 ± 5.9

6.7 ± 6.7

0.46

HbA1_C (%)

8.3 ± 2.1

8.4 ± 2.2

8.1 ± 1.9

0.39

TC (mg/dl)

170.6 ± 39.3

167.7 ± 39.6

174.2 ± 38.8

0.22

LDL-C (mg/dl)

100.8 ± 35.5

99 ± 34.5

103.1 ± 36.7

0.40

HDL-C (mg/dl)

47.5 ± 11.8

45.4 ± 11.3

50.1 ± 11.9

0.003

Triglyceride (mg/dl)

119 (83, 179)

128 (86,195)

102 (82, 156)

0.001

HsCRP (mg/dl)

0.11 (0.06-0.24)

0.1 (0.06, 0.24)

0.12 (0.06, 0.23)

0.50

HOMA-IR

3.8 (2.4, 5.8)

4.0 (2.4-6.1)

3.6 (2.3-5.2)

0.32

Mean ABI

1.14 ± 0.08

1.14 ± 0.09

1.14 ± 0.06

0.89

Mean baPWV (cm/sec)

1506 ± 313

1516 ± 320

1493 ± 304

0.59

Mean CIMT (mm)

0.48 ± 0.14

0.48 ± 0.15

0.49 ± 0.14

0.89

VFT (mm)

39 ± 16.1

41.9 ± 15.5

35.2 ± 16.2

0.002

SFT (mm)

14.5 ± 5.8

13.8 ± 6

15.3 ± 5.5

0.039

VFT/SFT Ratio

3.2 ± 2.1

3.5 ± 1.7

2.8 ± 2.4

0.01

ARB or ACEI, n(%)

94 (40.2%)

58 (44.3%)

36 (35.3%)

0.11

Statin, n (%)

133 (57%)

74 (56.5%)

59 (57.8%)

0.47

Antiplatelet agent, n (%)

105 (45%)

66 (50.4%)

39 (38.2%)

0.04

Thiazolidinediones, n (%)

21 (9%)

14 (10.7%)

7 (6.8%)

0.212

Smoking, n (%)

48 (20.7%)

43 (32.8%)

5 (5%)

<0.001

Prevalence of CVD, n (%)

27 (11.5%)

18 (13.7%)

7 (8.7%)

0.304

Prevalence of DN, n (%)

61 (26.1%)

39 (30%)

22 (21.4%)

0.073